Analysen von Keyur Parekh
15.03.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
10.03.17 | Merck Neutral | Goldman Sachs Group Inc. | |
28.02.17 | Sanofi Neutral | Goldman Sachs Group Inc. | |
09.02.17 | Sanofi Neutral | Goldman Sachs Group Inc. | |
06.02.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
24.01.17 | Sanofi Neutral | Goldman Sachs Group Inc. | |
24.01.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
24.01.17 | Merck Neutral | Goldman Sachs Group Inc. | |
Werbung
|
|||
06.01.17 | Sanofi Neutral | Goldman Sachs Group Inc. | |
07.11.16 | Sanofi Neutral | Goldman Sachs Group Inc. | |
19.10.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
17.10.16 | Merck Neutral | Goldman Sachs Group Inc. | |
10.10.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
07.09.16 | Bayer Neutral | Goldman Sachs Group Inc. | |
04.08.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
20.07.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
19.05.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
12.05.16 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
14.03.16 | Sanofi Neutral | Goldman Sachs Group Inc. | |
01.03.16 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
05.02.16 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
12.01.16 | Sanofi Neutral | Goldman Sachs Group Inc. | |
07.01.16 | Merck Neutral | Goldman Sachs Group Inc. | |
07.01.16 | Sanofi Neutral | Goldman Sachs Group Inc. | |
07.01.16 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
07.01.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
09.12.15 | Sanofi Neutral | Goldman Sachs Group Inc. | |
09.12.15 | Merck Neutral | Goldman Sachs Group Inc. | |
25.11.15 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
25.11.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
18.11.15 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
09.11.15 | Sanofi Neutral | Goldman Sachs Group Inc. | |
06.11.15 | Sanofi Neutral | Goldman Sachs Group Inc. | |
28.10.15 | Sanofi Neutral | Goldman Sachs Group Inc. | |
21.10.15 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
21.10.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
28.09.15 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
21.08.15 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
21.08.15 | Sanofi Neutral | Goldman Sachs Group Inc. | |
31.07.15 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
27.07.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
17.07.15 | Sanofi Neutral | Goldman Sachs Group Inc. | |
05.06.15 | Sanofi Neutral | Goldman Sachs Group Inc. | |
05.06.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
05.06.15 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
27.04.15 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
03.03.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
06.02.15 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
16.01.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
07.11.14 | AstraZeneca Neutral | Goldman Sachs Group Inc. |